Cargando…
New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method
Background: The faecal calprotectin (FC) measurement is used for inflammatory bowel disease (IBD) diagnosis and follow-up. The aim of this study was to validate for the first time the new IDS FC extraction device and immunoassay kit, and to compare it with the DiaSorin test in patients with and with...
Autores principales: | Castiglione, Vincent, Berodes, Maëlle, Lukas, Pierre, Louis, Edouard, Cavalier, Etienne, Lutteri, Laurence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600005/ https://www.ncbi.nlm.nih.gov/pubmed/36292026 http://dx.doi.org/10.3390/diagnostics12102338 |
Ejemplares similares
-
Analytical and clinical evaluation of DiaSorin Liaison® Calprotectin fecal assay adapted for serum samples
por: Macias‐Muñoz, Laura, et al.
Publicado: (2022) -
Analytical and clinical performance of the fully-automated LIAISONXL calprotectin immunoassay from DiaSorin in IBD patients
por: Vicente-Steijn, R., et al.
Publicado: (2020) -
Clinical Utilization of DiaSorin Molecular Polymerase Chain Reaction in Pneumocystis Pneumonia
por: Damhorst, Gregory L, et al.
Publicado: (2022) -
Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay
por: Salvagno, Gian Luca, et al.
Publicado: (2021) -
A Tale of Two Countries: DiaSorin Molecular’s Rapid Response to the COVID-19 Pandemic
por: Tabb, Michelle M., et al.
Publicado: (2022)